Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry

Ítems similars

• Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth
  per: WANG, Youjin, et al.
  Publicat: (2019)
• Preterm Birth and Low Birth Weight after In Utero Exposure to Antiretrovirals Initiated during Pregnancy in Yaoundé, Cameroon
  per: Njom Nlend, Anne Esther, et al.
  Publicat: (2016)
• In utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns
  per: LIN, Shu-Hong, et al.
  Publicat: (2021)
• Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa
  per: Mehta, Ushma C., et al.
  Publicat: (2019)
• Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women
  per: Malaba, Thokozile R, et al.
  Publicat: (2017)